Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity

American Journal of Cardiology

Volumn 82, Issue 10, 1998, Pages 1296-1298

  Faggiano, Pompilio ^a,b,c   D'Aloia, Antonio ^a,b   Gualeni, Anna ^a,b   Ambrosino, Nicolino ^a,b   Pagani, Marco ^a,b   Giordano, Amerigo ^a,b  

^a Cardiol Divisions of S Orsola H   (Italy)

^b IRCCS   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARBON MONOXIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; LOOP DIURETIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOTONIC AGENTS; DOBUTAMINE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY WEDGE PRESSURE; RESPIRATORY FUNCTION TESTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032533437     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00622-5     Document Type: Article

References (17)

1. 1. Akhtar N, Mikulic E, Cohn JN, Chaudhry MH. Hemodynamic effect of dobutamine in patients with severe heart failure. Am J Cardiol 1975;36:202-205.
2. 2. Loeb HS, Khan M, Saudye A, Gunnar RM. Acute hemodynamic effects of dobutamine and isoproterenol in patients with low output cardiac failure. Circulatory Shock 1976;3: 55-63.
3. 3. Loeb HS, Bredakis J, Gunnar RM. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 1977;55:375-381.
4. 4. Leier CV, Webel J, Bush CA. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 1977; 56:468-472.
5. 5. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978;58:466-475.
6. 6. Pozen RG, DiBianco R, Katz RJ, Bortz R, Myerburg RJ, Fletcher RD. Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease. Circulation 1981;63:1279-1285.
7. 7. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. Am J Cardiol 1986;58:110-116.
8. 8. Eichhorn EJ, Konstam MA, Weiland DS, Roberts DJ, Martin TT, Stransky NB, Salem DN. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:1329-1333.
9. 9. Baumann G, Felix SB, Filcek SAL. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output. Am J Cardiol 1990;65:748-754.
10. 10. Berkowitz C, McKeever L, Croke RP, Jacobs WR, Loeb HS, Gunnar RM. Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure. Circulation 1977;56:918-924.
11. 11. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JMB, Cleland JGF. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure: its pathophysiological relevance and relationship to exercise performance. Circulation 1995;91:2769-2774.
12. 12. Grossmann W. Evaluation of systolic and diastolic function of the myocardium. In: Grossmann W, Baim DS, eds. Cardiac Catheterization, Angiography and Intervention, 4th ed. Philadelphia: Lea & Febiger, 1991:319-339.
13. 13. Quanjer PH, Standardized lung function testing: report of the Working Party for the Standardization of Lung Function Tests of the European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983;19(suppl 5):1-95.
14. 14. European Respiratory Society. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993;6(suppl 16):41-52.
15. 15. Faggiano P, D'Aloia A, Simoni P, Gualeni A, Foglio K, Ambrosino N, Giordano A. Effects of body position on the carbon monoxide diffusing capacity in patients with chronic heart failure: relation to hemodynamic changes. Cardiology 1998;89:1-7.
16. 16. Janicki JS, Weber KT, Likoff MJ, Fishman AP. The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 1985;72:1270-1278.
17. 17. Puri S, Baker BL, Oakley CM, Hughes JMB, Cleland JGF. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J 1994;72:140-144.